{
  "id": 12604263,
  "name": "AMGEN INC., et al, petitioners, v. SANDOZ INC.",
  "name_abbreviation": "Amgen Inc. v. Sandoz Inc.",
  "decision_date": "2017-04-13",
  "docket_number": "No. 15\u20131195.",
  "first_page": "1454",
  "last_page": "1454",
  "citations": [
    {
      "type": "official",
      "cite": "137 S. Ct. 1454"
    },
    {
      "type": "parallel",
      "cite": "197 L. Ed. 2d 698"
    }
  ],
  "court": {
    "name_abbreviation": "U.S.",
    "id": 9009,
    "name": "Supreme Court of the United States"
  },
  "jurisdiction": {
    "id": 39,
    "name_long": "United States",
    "name": "U.S."
  },
  "cites_to": [],
  "analysis": {
    "cardinality": 36,
    "char_count": 247,
    "sha256": "03317fa13014adcc1f04f8784e979345774f69d63caff04c7f7b607cdb560d54",
    "simhash": "1:f0c4240382c4ce55",
    "word_count": 41
  },
  "last_updated": "2021-08-27T21:04:35.134644+00:00",
  "provenance": {
    "date_added": "2021-08-27",
    "source": "Fastcase",
    "batch": "2021"
  },
  "casebody": {
    "judges": [],
    "parties": [
      "AMGEN INC., et al, petitioners,\nv.\nSANDOZ INC."
    ],
    "opinions": [
      {
        "text": "",
        "type": "majority",
        "author": null
      }
    ],
    "attorneys": [
      "Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument is granted."
    ],
    "corrections": "",
    "head_matter": "AMGEN INC., et al, petitioners,\nv.\nSANDOZ INC.\nNo. 15-1195.\nSupreme Court of the United States\nApril 13, 2017.\nMotion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument is granted."
  },
  "file_name": "1454-02",
  "first_page_order": 1454,
  "last_page_order": 1454
}
